BioSpace News Archive

Business

LeMaitre Vascular, Inc. Will Announce First Quarter 2015 Earnings Results On April 28, 2015

April 20, 2015
·
1 min read
Drug Development

Early Findings With KEYTRUDA (Pembrolizumab), Merck & Co.’s Anti-PD-1 Therapy, In Patients With Advanced Pleural Mesothelioma Presented At American Association for Cancer Research Annual Meeting

April 20, 2015
·
12 min read
Drug Development

KEYTRUDA (Pembrolizumab), Merck & Co.’s Anti-PD-1 Therapy, Demonstrates Superior Survival, Progression Free Survival And Overall Response Rate Compared To Ipilimumab An Anti-CTLA-4 Therapy

April 20, 2015
·
15 min read
Job Trends

NeuroVive Sets Up Shop in France and Intends to Hire for R&D

April 20, 2015
·
4 min read
Drug Development

Full Data On Baxter International’s Investigational Recombinant Treatment BAX 111 Supports Potential Role To Treat Von Willebrand Disease

April 20, 2015
·
5 min read
Drug Development

Anika Therapeutics’ Cingal 13-02 Study Meets Primary Endpoint

April 20, 2015
·
6 min read
Drug Development

Published Phase 2 Results Demonstrate Neuraltus Pharmaceuticals, Inc.'s NP001 Potential Efficacy And Safety In ALS

April 20, 2015
·
7 min read
Business

PPD, Inc. Opens Central Lab In Shanghai, China

April 20, 2015
·
4 min read
Drug Development

Pluristem Therapeutics’s Clinical Advisory Board Prepares Phase II Clinical Trials In Critical Limb Ischemia In Europe And Japan

April 20, 2015
·
4 min read
Drug Development

Cyclacel Pharmaceuticals, Inc.'s Second-Generation CDK2/9 Inhibitor, CYC065, Demonstrates Therapeutic Potential And Synergy With Other Anti-Cancer Compounds

April 20, 2015
·
11 min read